Pan-coronavirus viral components (Pan-CoV components)

Pan-coronavirus viral components refer to a group of highly conserved proteins and structural elements shared across the Coronaviridae family, including SARS-CoV-2, SARS-CoV, and MERS-CoV (PMID: 32733101). These components are the focus of broad-spectrum antiviral research aimed at creating pan-coronavirus therapies that remain effective despite the emergence of new variants (Nature, doi: 10.1038/s41586-022-04596-x). The most prominent targets within this group are the RNA-dependent RNA polymerase (RdRp), which is responsible for replicating the viral genome, and the main protease (Mpro or 3CLpro), which is essential for cleaving viral polyproteins into functional units (PMID: 32272237). Other conserved targets include the papain-like protease (PLpro) and the S2 subunit of the spike protein, which mediates viral-host membrane fusion (PMID: 33053324). Drugs such as remdesivir and nirmatrelvir target these conserved enzymes to inhibit the viral life cycle across multiple species (PMID: 32445440, PMID: 34919958). The primary therapeutic challenge involves the high rate of viral mutation, which can lead to drug resistance, and the need for high specificity to avoid interfering with host cellular processes.

Other names

Conserved coronavirus proteinsPan-CoV targetsBroad-spectrum coronavirus targetsConserved viral elements

Inhibition of highly conserved viral enzymes, primarily the RNA-dependent RNA polymerase (RdRp) and the main protease (Mpro/3CLpro), to prevent viral replication and polyprotein processing across multiple coronavirus species.